Michael D Hogarty Selected Research

Michael D Hogarty Research Topics

Disease

51	Neuroblastoma 01/2022 - 04/2003
44	Neoplasms (Cancer) 01/2022 - 08/2003
5	Carcinogenesis 10/2018 - 12/2008
2	Ganglioneuroma 03/2013 - 10/2009
2	Ganglioneuroblastoma 03/2013 - 10/2009
1	Bites and Stings (Sting) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2021
1	Hypertrophy 01/2021
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Lymphoma (Lymphomas) 10/2019
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2018
1	Genetic Translocation (Chromosomal Translocation) 10/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017
1	African Trypanosomiasis (Nagana) 07/2015
1	Encephalitis (Encephalitis, Rasmussen) 07/2015
1	Circulating Neoplastic Cells 02/2014
1	Triple Negative Breast Neoplasms 03/2013
1	Prostatic Neoplasms (Prostate Cancer) 03/2013

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
8	PolyaminesIBA 04/2021 - 12/2008
7	Biological ProductsIBA 12/2019 - 08/2003
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2013
6	EnzymesIBA 04/2021 - 12/2008
5	Eflornithine (Ornidyl)FDA Link 01/2019 - 12/2008
4	N-Myc Proto-Oncogene ProteinIBA 01/2021 - 03/2013
4	Pharmaceutical PreparationsIBA 01/2020 - 03/2013
3	LigandsIBA 10/2019 - 01/2017
3	CationsIBA 01/2019 - 01/2012
3	MicroRNAs (MicroRNA)IBA 12/2018 - 05/2009
3	Phosphotransferases (Kinase)IBA 07/2015 - 07/2006
3	Messenger RNA (mRNA)IBA 01/2012 - 04/2003
2	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2009
2	Oncogene Proteins (Oncogene Protein)IBA 04/2021 - 04/2003
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 04/2021 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019 - 04/2007
2	Transcription Factors (Transcription Factor)IBA 10/2018 - 10/2017
2	Small Interfering RNA (siRNA)IBA 10/2018 - 05/2009
2	dinutuximabIBA 01/2018 - 01/2017
2	Isotretinoin (Accutane)FDA LinkGeneric 01/2018 - 01/2017
2	Protein Isoforms (Isoforms)IBA 01/2017 - 08/2003
2	Complement System Proteins (Complement)IBA 07/2015 - 10/2005
2	ABT-737IBA 03/2013 - 05/2012
2	OligonucleotidesIBA 05/2009 - 04/2003
2	Antisense OligonucleotidesIBA 05/2009 - 04/2007
1	CeramidesIBA 01/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	InterferonsIBA 01/2022
1	CytokinesIBA 01/2022
1	AntigensIBA 01/2021
1	Busulfan (Busulfex)FDA Link 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	mapatumumabIBA 10/2019
1	Death Domain ReceptorsIBA 10/2019
1	Heavy Chain Fusion Regulatory Protein 1IBA 01/2019
1	SpermidineIBA 01/2019
1	Circulating MicroRNAIBA 12/2018
1	ChromatinIBA 10/2018
1	Histones (Histone)IBA 10/2018
1	RG7388IBA 03/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	RNA-Binding Protein EWSIBA 10/2017
1	EWS-FLI fusion proteinIBA 10/2017
1	YK 4-279IBA 10/2017
1	Vincristine (Oncovin)FDA LinkGeneric 10/2017
1	HLA-Bw4 antigenIBA 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Celecoxib (Celebrex)FDA Link 09/2016
1	NucleotidesIBA 08/2016
1	Mitochondrial DNA (mtDNA)IBA 08/2016
1	Cell-Free Nucleic AcidsIBA 01/2016
1	AgarIBA 07/2015
1	Apoptosis Regulatory ProteinsIBA 01/2015
1	tyrosine receptor (receptor, tyrosine)IBA 01/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2015
1	Cell Surface ReceptorsIBA 11/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2014
1	Anaplastic Lymphoma KinaseIBA 11/2014
1	Circulating Tumor DNAIBA 02/2014
1	Androgen Receptors (Androgen Receptor)IBA 03/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2013
1	Antineoplastic Agents (Antineoplastics)IBA 03/2013
1	navitoclaxIBA 03/2013

Therapy/Procedure

21	Therapeutics 01/2022 - 10/2005
9	Drug Therapy (Chemotherapy) 01/2021 - 08/2009
7	Immunotherapy 01/2022 - 07/2015
2	Induction Chemotherapy 01/2021 - 01/2019
2	Radiotherapy 07/2015 - 12/2010
1	Stem Cell Transplantation 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2020
1	Duration of Therapy 12/2019